Clinical trial

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

NCT03418831

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-17

PhasePHASE4

Study timeline

Study start (actual)2018-07-17Date precision: day

Registry last updated2019-09-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Raloxifene HydrochlorideDRUG · verified · RxNorm: raloxifene hydrochloride

PlaceboOTHER

Sponsors & collaborators

Shanghai Mental Health Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03418831 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.